BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21944855)

  • 1. Synthesis and evaluation of pyridazinone-phenethylamine derivatives as selective and orally bioavailable histamine H3 receptor antagonists with robust wake-promoting activity.
    Dandu RR; Gruner JA; Mathiasen JR; Aimone LD; Hostetler G; Benfield C; Bendesky RJ; Marcy VR; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2011 Nov; 21(21):6362-5. PubMed ID: 21944855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pyridazin-3-one derivatives as potent, selective histamine H₃ receptor inverse agonists with robust wake activity.
    Hudkins RL; Aimone LD; Bailey TR; Bendesky RJ; Dandu RR; Dunn D; Gruner JA; Josef KA; Lin YG; Lyons J; Marcy VR; Mathiasen JR; Sundar BG; Tao M; Zulli AL; Raddatz R; Bacon ER
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5493-7. PubMed ID: 21782432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of 5-pyridazin-3-one phenoxypropylamines as potent, selective histamine H₃ receptor antagonists with potent cognition enhancing activity.
    Tao M; Aimone LD; Huang Z; Mathiasen J; Raddatz R; Lyons J; Hudkins RL
    J Med Chem; 2012 Jan; 55(1):414-23. PubMed ID: 22107017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amine-constrained pyridazinone histamine H₃ receptor antagonists.
    Sundar BG; Bailey T; Bacon E; Aimone L; Huang Z; Lyons J; Raddatz R; Hudkins R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5543-6. PubMed ID: 21824776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
    Le S; Gruner JA; Mathiasen JR; Marino MJ; Schaffhauser H
    J Pharmacol Exp Ther; 2008 Jun; 325(3):902-9. PubMed ID: 18305012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new family of H3 receptor antagonists based on the natural product Conessine.
    Santora VJ; Covel JA; Hayashi R; Hofilena BJ; Ibarra JB; Pulley MD; Weinhouse MI; Sengupta D; Duffield JJ; Semple G; Webb RR; Sage C; Ren A; Pereira G; Knudsen J; Edwards JE; Suarez M; Frazer J; Thomsen W; Hauser E; Whelan K; Grottick AJ
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1490-4. PubMed ID: 18194865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of pyridone-phenoxypropyl-R-2-methylpyrrolidine analogues as histamine H3 receptor antagonists.
    Becknell NC; Lyons JA; Aimone LD; Gruner JA; Mathiasen JR; Raddatz R; Hudkins RL
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7076-80. PubMed ID: 22014551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-(1'-Cyclobutylspiro[4H-1,3-benzodioxine-2,4'-piperidine]-6-yl)-5,5-dimethyl-1,4-dihydropyridazin-6-one (CEP-32215), a new wake-promoting histamine H3 antagonist/inverse agonist.
    Hudkins RL; Gruner JA; Raddatz R; Mathiasen JR; Aimone LD; Marino MJ; Bacon ER; Williams M; Ator MA
    Neuropharmacology; 2016 Jul; 106():37-45. PubMed ID: 26400408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
    Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,5-dihydropyridazin-3-one derivatives as histamine H₃ receptor inverse agonists.
    Hudkins RL; Aimone LD; Dandu RR; Dunn D; Gruner JA; Huang Z; Josef KA; Lyons JA; Mathiasen JR; Tao M; Zulli AL; Raddatz R
    Bioorg Med Chem Lett; 2012 Jan; 22(1):194-8. PubMed ID: 22142542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Aryloxymethylmorpholine histamine H(3) antagonists.
    Letavic MA; Keith JM; Ly KS; Bonaventure P; Feinstein MA; Lord B; Miller KL; Motley ST; Nepomuceno D; Sutton SW; Carruthers NI
    Bioorg Med Chem Lett; 2008 Nov; 18(21):5796-9. PubMed ID: 18922693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.
    Becknell NC; Lyons JA; Aimone LD; Huang Z; Gruner JA; Raddatz R; Hudkins RL
    Bioorg Med Chem; 2012 Jun; 20(12):3880-6. PubMed ID: 22578490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
    Gao Z; Hurst WJ; Czechtizky W; Francon D; Griebel G; Nagorny R; Pichat P; Schwink L; Stengelin S; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6141-5. PubMed ID: 24076172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a new series of 1'-cyclobutyl-6-(4-piperidyloxy)spiro[benzopyran-2,4'-piperidine] derivatives as high affinity and selective histamine-3 receptor (H3R) antagonists.
    Dandu RR; Lyons JA; Raddatz R; Huang Z; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2151-3. PubMed ID: 22365751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole- and benzothiophene-based histamine H3 antagonists.
    Santillan A; McClure KJ; Allison BD; Lord B; Boggs JD; Morton KL; Everson AM; Nepomuceno D; Letavic MA; Lee-Dutra A; Lovenberg TW; Carruthers NI; Grice CA
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6226-30. PubMed ID: 20843691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.
    Tao M; Raddatz R; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6126-30. PubMed ID: 21906941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists.
    Shao N; Aslanian R; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J; Palani A
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2075-8. PubMed ID: 22326166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diamine derivatives containing imidazolidinylidene propanedinitrile as a new class of histamine H3 receptor antagonists. Part I.
    Sasho S; Seishi T; Kawamura M; Hirose R; Toki S; Shimada JI
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2288-91. PubMed ID: 18353639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity.
    Sundar BG; Bailey TR; Dunn D; Hostetler GA; Chatterjee S; Bacon ER; Yue C; Schweizer D; Aimone LD; Gruner JA; Lyons J; Raddatz R; Lesur B
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1546-9. PubMed ID: 22297111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-phenoxypiperidine pyridazin-3-one histamine H(3) receptor inverse agonists demonstrating potent and robust wake promoting activity.
    Hudkins RL; Zulli AL; Dandu Rr; Tao M; Josef KA; Aimone LD; Haltiwanger RC; Huang Z; Lyons JA; Mathiasen JR; Raddatz R; Gruner JA
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1504-9. PubMed ID: 22290075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.